Back to welcome
Back to languageselection
ST:
morbidity
No:1100
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
diseased state
RF1: C
YR1: 1992
CO1:
LU:
ST:
morphinomimetic
No:1101
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
simulating effects of morphine
RF1: OT/E
YR1:
CO1:
LU:
ST:
mortality
No:1102
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
mortality
RF1: ID
YR1:
CO1:
LU:
ST:
motility
No:1103
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
ability to move spontaneously
RF1: E
YR1: 1994
CO1:
LU:
ST:
motor
No:1104
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
motor
RF1: ID
YR1:
CO1:
LU:
ST:
mucociliary
No:1105
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
mucous membrane and hair-related
RF1: OT/E
YR1:
CO1:
LU:
ST:
mucocutaneous
No:1106
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
mucous membrane and skin-related
RF1: OT/E
YR1:
CO1:
LU:
ST:
mucolytic
No:1107
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
main part of mucous
RF1: OT/E
YR1:
CO1:
LU:
ST:
mucopurulent
No:1108
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
containing mucus and pus
RF1: E
YR1: 1994
CO1:
LU:
ST:
mucosa
No:1109
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
mucose membrane
RF1: E
YR1: 1992
CO1:
LU:
ST:
mucus
No:1110
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
mucus
RF1: ID
YR1:
CO1:
LU:
ST:
multidose
No:1111
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
multidose
RF1: ID
YR1:
CO1:
LU:
ST:
multiparous
No:1112
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
woman who has had 2 or more babies
RF1: OT/C
YR1:
CO1:
LU:
ST:
multiple
No:1113
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
multiple
RF1: ID
YR1:
CO1:
LU:
ST:
muscle relaxant
No:1114
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscle relaxant
RF1: ID
YR1:
CO1:
LU:
ST:
muscular
No:1115
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscular
RF1: ID
YR1:
CO1:
LU:
ST:
musculature
No:1116
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscles
RF1: OT
YR1:
CO1:
LU:
ST:
mutagenic
No:1117
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
causing genetic mutation
RF1: OT/E
YR1:
CO1:
LU:
ST:
mutation
No:1118
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
mutation
RF1: ID
YR1:
CO1:
LU:
ST:
mutism
No:1119
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
dumbness
RF1: OT
YR1:
CO1:
LU:
ST:
myalgia
No:1120
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscle pain
RF1: OT/E
YR1:
CO1:
LU:
ST:
myasthenia
No:1121
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscle weakness
RF1: C
YR1: 1992
CO1:
LU:
ST:
mycobacterium
No:1122
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bacteria
RF1: OT/E
YR1:
CO1:
LU:
ST:
mycological
No:1123
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
fungus study-related
RF1: OT/E
YR1:
CO1:
LU:
ST:
mycosis
No:1124
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
fungal disease
RF1: E
YR1: 1992
CO1:
LU:
ST:
mycotic
No:1125
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
caused by a fungus
RF1: E
YR1: 1994
CO1:
LU:
ST:
mydriatic
No:1126
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
pupil-dilating drug
RF1: OT/e
YR1:
CO1:
LU:
ST:
myeloma
No:1127
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bone marrow cancer
RF1: OT/E
YR1:
CO1:
LU:
ST:
myelomatosis
No:1128
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bone marrow cancer
RF1: OT/E
YR1:
CO1:
LU:
ST:
myelosuppression
No:1129
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
stopping bone marrow activity
RF1: E
YR1: 1992
CO1:
LU:
ST:
myelotoxic
No:1130
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
destructive to bone marrow
RF1: E
YR1: 1994
CO1:
LU:
ST:
myocarditis
No:1131
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
heart inflammation
RF1: C
YR1: 1992
CO1:
LU:
ST:
myopathy
No:1132
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscle diease
RF1: C
YR1: 1992
CO1:
LU:
ST:
myopia
No:1133
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
short-sightedness
RF1: OT
YR1:
CO1:
LU:
ST:
myositis
No:1134
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
muscle inflammation
RF1: OT/C
YR1:
CO1:
LU:
ST:
nadir
No:1135
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
low
point
RF1: OT
YR1:
CO1:
LU:
ST:
narcotic
No:1136
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
morphine-like drug
RF1: OT/E
YR1:
CO1:
LU:
ST:
nasal
No:1137
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
nose-related
RF1: OT
YR1:
CO1:
LU:
ST:
nasolacrimal
No:1138
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
nose and tear duct related
RF1: OT/E
YR1:
CO1:
LU:
ST:
natriuresis
No:1139
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
excretion of sodium by kidneys
RF1: C
YR1: 1992
CO1:
LU:
ST:
nausea
No:1140
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
feeling sick
RF1: OT
YR1:
CO1:
LU:
ST:
necrolysis
No:1141
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
gangrene
RF1: C
YR1: 1992
CO1:
LU:
ST:
necrosis
No:1142
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
gangrene
RF1: C
YR1: 1992
CO1:
LU:
ST:
negative
No:1143
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
negative
RF1: ID
YR1:
CO1:
LU:
ST:
neonatal
No:1144
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
new baby-related
RF1: OT
YR1:
CO1:
LU:
ST:
neoplastic
No:1145
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
tumour-related
RF1: C
YR1: 1992
CO1:
LU:
ST:
nephritis
No:1146
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
kidney inflammation
RF1: C
YR1: 1992
CO1:
LU:
ST:
nephrolith
No:1147
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
kidney stone
RF1: OT/E
YR1:
CO1:
LU:
ST:
nephropathy
No:1148
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
kidney disease
RF1: C
YR1: 1992
CO1:
LU:
ST:
nephrotic
No:1149
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
kidney disorder-related
RF1: OT/C
YR1:
CO1:
LU: